Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions (Q36967164)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2007

Language	Label	Description	Also known as
English	Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions	scientific article published on January 2007

Statements

scholarly article

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions (English)

1 reference

Europe PubMed Central

17 August 2017

Caroline M Perry

2

object named as

Caroline M Perry

1 reference

Europe PubMed Central

17 August 2017

Antona J Wagstaff

1

object named as

Antona J Wagstaff

1 reference

Europe PubMed Central

17 August 2017

publication date

1 January 2007

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

67

1 reference

Europe PubMed Central

17 August 2017

15

1 reference

Europe PubMed Central

17 August 2017

2187-2210

1 reference

Europe PubMed Central

17 August 2017

https://scigraph.springernature.com/pub.10.2165/00003495-200767150-00006

0 references

A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767150-00006

21 January 2018

Topical imiquimod 5% cream in external anogenital warts: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767150-00006

21 January 2018

Acute urinary retention following self treatment of genital warts with imiquimod 5% cream

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of imiquimod 5% cream for basal cell carcinoma in transplant patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A case of severe eczema following use of imiquimod 5% cream

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of lymphomatoid papulosis with imiquimod 5% cream

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Percutaneous penetration of Aldara cream, 5% during the topical treatment of genital and perianal warts

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angioedema associated with imiquimod

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fifty-five basal cell carcinomas treated with topical imiquimod: outcome at 5-year follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topical 5% imiquimod long-term treatment of cutaneous warts resistant to standard therapy modalities

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficiency of topical imiquimod 5% cream in the management of chronic radiation dermatitis with multiple neoplasias.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imiquimod: potential risk of an immunostimulant

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Porokeratosis of Mibelli of the axillae: treatment with topical imiquimod

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Established and potential strategies against papillomavirus infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of imiquimod cream 5% for treating childhood molluscum contagiosum in a double-blind, randomized pilot trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of a therapy-resistant pyogenic granuloma with topical imiquimod 5% cream

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imiquimod 5% cream in the treatment of Bowen's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic response of a brother and sister with xeroderma pigmentosum to imiquimod 5% cream

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vulvitis circumscripta plasmacellularis: success with a modified treatment regimen using imiquimod

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anal intraepithelial neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First case series on the use of imiquimod for morphoea

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imiquimod to treat different cancers of the epidermis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psoriasis induced by topical imiquimod

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of multiple trichoepitheliomas with topical imiquimod and tretinoin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of lentigo maligna with topical imiquimod.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imiquimod: an effective alternative for the treatment of invasive cutaneous squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interventions for basal cell carcinoma of the skin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of lentigo maligna (melanoma in situ) with the immune response modifier imiquimod

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A case of generalized discoid lupus erythematosus: successful treatment with imiquimod cream 5%.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Application of imiquimod by suppositories (anal tampons) efficiently prevents recurrences after ablation of anal canal condyloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Final results of a phase 2 study using continuous 5% Imiquimod cream application in the primary treatment of high-grade vulva intraepithelial neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granuloma annulare resolved with topical application of imiquimod

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apparent response of cutaneous Merkel cell tumor to topical imiquimod

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imiquimod cream 5% for recalcitrant cutaneous warts in immunosuppressed individuals.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lip silicone granulomatous foreign body reaction treated with aldara (imiquimod 5%).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imiquimod therapy for elastosis perforans serpiginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study of treatment of lentigo maligna with 5% imiquimod cream

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localized pemphigus foliaceus induced by topical imiquimod treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis of 5% imiquimod and 0.5% podophyllotoxin in the treatment of condylomata acuminata

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topical imiquimod: a review of its use in genital warts

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human papillomavirus type 5 infection in a patient with Hailey-Hailey disease successfully treated with imiquimod

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postsurgical use of imiquimod 5% cream in the prevention of earlobe keloid recurrences: results of an open-label, pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imiquimod as an antiangiogenic agent.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular analysis of the effect of topical imiquimod treatment of HPV 2/27/57-induced common warts

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of invasive squamous cell carcinoma with 5-percent imiquimod cream

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Porokeratosis of Mibelli: successful treatment with 5% imiquimod cream

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proliferating hemangioma of infancy: successful treatment with topical 5% imiquimod cream

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infantile hemangioma: clinical resolution with 5% imiquimod cream

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5% Imiquimod cream for external anogenital warts in HIV-infected patients under HAART therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of precancerous and cancerous lesions of chronic arsenicism with 5% imiquimod cream.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In situ photoimmunotherapy: a tumour-directed treatment for melanoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost-effectiveness of patient-applied treatments for anogenital warts

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An open label evaluation of the efficacy of imiquimod 5% cream in the treatment of recalcitrant subungual and periungual cutaneous warts

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The antitumoral mode of action of imiquimod and other imidazoquinolines

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aphthous ulcers associated with imiquimod and the treatment of actinic cheilitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrent pyogenic granuloma treated with topical imiquimod

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of genital warts with an immune-response modifier (imiquimod).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aphthous ulcers and imiquimod

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topical imiquimod immunotherapy in the management of lentigo maligna

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of multiple giant molluscum contagiosum in a renal transplant patient with imiquimod 5% cream

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5% imiquimod suppositories decrease the DNA load of intra-anal HPV types 6 and 11 in HIV-infected men after surgical ablation of condylomata acuminata

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genital infection with human papillomavirus in adolescents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of atypical nevi with imiquimod 5% cream

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Porokeratosis of Mibelli: successful treatment with topical 5% imiquimod cream

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adult cutaneous Langerhans cell histiocytosis responsive to topical imiquimod

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of undifferentiated vulvar intraepithelial neoplasia with 5% imiquimod cream: a prospective study of 12 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infiltrative trichilemmal carcinoma treated with 5% imiquimod cream

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term clinical outcomes following treatment of actinic keratosis with imiquimod 5% cream.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Direct medical costs for surgical and medical treatment of condylomata acuminata.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pilot study of imiquimod 5% cream as adjunctive therapy to curettage and electrodesiccation for nodular basal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiolymphoid hyperplasia with eosinophilia successfully treated with imiquimod

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): A randomized, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imiquimod for the treatment of actinic keratosis: A meta-analysis of randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic side effects from topical imiquimod.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of vaginal intraepithelial neoplasia (primarily low grade) with imiquimod 5% cream

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased frequency of dosing of imiquimod 5% cream in the treatment of external genital warts in women

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imiquimod therapy for molluscum contagiosum

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imiquimod 5% cream in the treatment of mycosis fungoides--a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I/II study of topical imiquimod and intralesional interleukin-2 in the treatment of accessible metastases in malignant melanoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recalcitrant molluscum contagiosum in an HIV-afflicted male treated successfully with topical imiquimod

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of 5% imiquimod cream on high-grade vulval intraepithelial neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of porokeratosis of Mibelli with imiquimod 5% cream

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of human papillomavirus and response to topical 5% imiquimod in a case of stucco keratosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of molluscum contagiosum with topical imiquimod in a severely immunocompromised HIV-positive patient

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topical treatment with imiquimod may induce regression of facial keratoacanthoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imiquimod for actinic keratosis: systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bowen's disease (squamous cell carcinoma in situ) in immunosuppressed patients treated with imiquimod 5% cream and a cox inhibitor, sulindac: potential applications for this combination of immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topical imiquimod therapy for chronic giant molluscum contagiosum in a patient with advanced human immunodeficiency virus 1 disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resolution of vulvitis circumscripta plasmacellularis with topical imiquimod: two case reports

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety studies of topical imiquimod 5% cream on normal skin exposed to ultraviolet radiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atypical lymphocytic reaction with epidermotropism and lymphocytic vasculopathic reaction (lymphocytic vasculitis) after treatment with imiquimod

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of bowenoid and basaloid vulvar intraepithelial neoplasia 2/3 with imiquimod 5% cream.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A patient with xeroderma pigmentosum treated with imiquimod 5% cream

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of genital human papillomavirus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of dysplastic nevi with 5% imiquimod cream, a pilot study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imiquimod in the treatment of multifocal vulvar intraepithelial neoplasia 2/3. Results of a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, comparative trial on the sustained efficacy of topical imiquimod 5% cream versus conventional ablative methods in external anogenital warts

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Actinic keratoses: sequelae and treatments. Recommendations from a consensus panel

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topical imiquimod treatment prevents UV-light induced loss of contact hypersensitivity and immune tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/17927284

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-200767150-00006

1 reference

Europe PubMed Central

17 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36967164&oldid=1664651821"